Five years on: What are the community perceptions of drug-related public amenity following the establishment of the Sydney Medically Supervised Injecting Centre?

Salmon, Allison M.; Thein, Hla-Hla; Kimber, Jo; Kaldor, John; Maher, Lisa

doi:10.1016/j.drugpo.2006.11.010

Cited by 67 publications

(60 citation statements)

References 12 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…These restrictions, in part, divert PWID to unsafe and unhygienic injecting locations within their community such as business bathrooms. Research also suggests that SIF/DCR are capable of successfully managing overdoses, reducing overdose deaths, reducing HIV/HCV risk behaviour, increase uptake of addiction treatment, reduce public injection and public disorder while not increasing drug injection initiation, community drug use, or drug related crime and being cost-effective (Andresen & Boyd, 2010; DeBeck et al, 2011; Freeman et al, 2005; Kerr, Kimber, DeBeck, & Wood, 2007; Kerr et al, 2006; Kerr, Tyndall, Li, Montaner, & Wood, 2005; Kerr, Tyndall et al, 2007; Marshall, Milloy, Wood, Montaner, & Kerr, 2011; Petrar et al, 2007; Salmon, Thein, Kimber, Kaldor, & Maher, 2007; Small, Van Borek, Fairbairn, Wood, & Kerr, 2009; Stoltz et al, 2007; Wood et al, 2004; Wood, Tyndall, Lai, Montaner, & Kerr, 2006; Wood, Tyndall, Zhang, Montaner, & Kerr, 2007; Wood, Tyndall, Zhang et al, 2006). Supervised injection facilities and drug consumption rooms also have the ability to reduce both public injection and improperly disposed syringe sightings as reported by researchers, local residents, and business managers in Vancouver, BC, Canada and Sydney, NSW, Australia making this intervention worthy of further investigation in addition to the education and training of managers in overdose recognition and naloxone use (Petrar et al, 2007; Salmon et al, 2007; Stoltz et al, 2007; Wood et al, 2004).…”

Section: Discussionmentioning

confidence: 99%

Drug use in business bathrooms: An exploratory study of manager encounters in New York City

Wolfson‐Stofko

Bennett

Elliott

et al. 2017

International Journal of Drug Policy

View full text Add to dashboard Cite

Background Though public bathroom drug injection has been documented from the perspective of people who inject drugs, no research has explored the experiences of the business managers who oversee their business bathrooms and respond to drug use. These managers, by default, are first-responders in the event of a drug overdose and thus of intrinsic interest during the current epidemic of opioid-related overdoses in the United States. This exploratory study assists in elucidating the experiences that New York City business managers have with people who inject drugs, their paraphernalia, and their overdoses. Methods A survey instrument was designed to collect data on manager encounters with drug use occurring in their business bathrooms. Recruitment was guided by convenience and purposive approaches. Results More than half of managers interviewed (58%, n = 50/86) encountered drug use in their business bathrooms, more than a third (34%) of these managers also found syringes, and the vast majority (90%) of managers had received no overdose recognition or naloxone training. Seven managers encountered unresponsive individuals who required emergency assistance. Conclusion The results from this study underscore the need for additional research on the experiences that community stakeholders have with public injection as well as educational outreach efforts among business managers. This research also suggests that there is need for a national dialogue about potential interventions, including expanded overdose recognition and naloxone training and supervised injection facilities (SIF)/drug consumption rooms (DCR), that could reduce public injection and its associated health risks.

show abstract

Section: Discussionmentioning

confidence: 99%

Drug use in business bathrooms: An exploratory study of manager encounters in New York City

Wolfson‐Stofko

Bennett

Elliott

et al. 2017

International Journal of Drug Policy

View full text Add to dashboard Cite

show abstract

“…Rigorous evaluation of Insite, North America’s first legally sanctioned supervised injection site located in Vancouver, Canada, demonstrates that SIS reduce the risk of HIV transmission [16, 17] and fatal overdose [18] and increase the uptake of medical care and addiction treatment [19, 20]. The service has been shown to reduce the extent of public injecting and the number of discarded syringes and other injection-related litter in public spaces [7, 21]. Evaluations of the services from Australia have also demonstrated a reduced number of overdose-related ambulance callouts in the neighbourhoods surrounding the services [22].…”

Section: Introductionmentioning

confidence: 99%

Acceptability and design preferences of supervised injection services among people who inject drugs in a mid-sized Canadian City

et al. 2017

View full text Add to dashboard Cite

BackgroundSupervised injection services (SIS) have been shown to reduce the public- and individual-level harms associated with injection drug use. While SIS feasibility research has been conducted in large urban centres, little is known about the acceptability of these services among people who inject drugs (PWID) in mid-sized cities. We assessed the prevalence and correlates of willingness to use SIS as well as design and operational preferences among PWID in London, Canada.MethodsBetween March and April 2016, peer research associates administered a cross-sectional survey to PWID in London. Socio-demographic characteristics, drug-use patterns, and behaviours associated with willingness to use SIS were estimated using bivariable and multivariable logistic regression models. Chi-square tests were used to compare characteristics with expected frequency of SIS use among those willing to use SIS. Design and operational preferences are also described.ResultsOf 197 PWID included in this analysis (median age, 39; interquartile range (IQR), 33–50; 38% female), 170 (86%) reported willingness to use SIS. In multivariable analyses, being female (adjusted odds ratio (AOR) 0.29; 95% confidence interval (CI) 0.11–0.75) was negatively associated with willingness to use, while public injecting in the last 6 months (AOR 2.76; 95% CI 1.00–7.62) was positively associated with willingness to use. Participants living in unstable housing, those injecting in public, and those injecting opioids and crystal methamphetamine daily reported higher expected frequency of SIS use (p < 0.05). A majority preferred private cubicles for injecting spaces and daytime operational hours, while just under half preferred PWID involved in service operations.ConclusionsHigh levels of willingness to use SIS were found among PWID in this setting, suggesting that these services may play a role in addressing the harms associated with injection drug use. To maximize the uptake of SIS, programme planners and policy makers should consider the effects of gender and views of PWID regarding SIS design and operational preferences.

show abstract

“…For example, there are several reports of public drug use declining after the implementation of SIFs in several European cities [19,23,34,48,53] and in Sydney [54,55]. In Vancouver, in multivariate analyses, the establishment of a SIF was independently and positively associated with declines in the number of IDUs injecting in public, as well as the number of discarded syringes on city streets [14].…”

Section: Reducing Morbiditymentioning

confidence: 92%

The role of safer injection facilities in the response to HIV/AIDS among injection drug users

Kerr

Kimber²,

DeBeck³

et al. 2007

Curr HIV/AIDS Rep

Self Cite

View full text Add to dashboard Cite

Many cities throughout the globe are experiencing ongoing infectious disease and overdose epidemics among injection drug users (IDUs). In particular, HIV has become endemic among IDUs in many settings. In an effort to reduce this and related public health concerns, medically supervised safer injecting facilities (SIFs), where IDUs can inject pre-obtained illicit drugs under the supervision of medical staff, have been established in several countries. The following review assesses the role that SIFs can play in reducing the harms associated with HIV infection among IDUs and points to ways in which SIFs can be further developed to better respond to the challenges associated with HIV/AIDS among this population.

show abstract

Five years on: What are the community perceptions of drug-related public amenity following the establishment of the Sydney Medically Supervised Injecting Centre?

Cited by 67 publications

References 12 publications

Drug use in business bathrooms: An exploratory study of manager encounters in New York City

Drug use in business bathrooms: An exploratory study of manager encounters in New York City

Acceptability and design preferences of supervised injection services among people who inject drugs in a mid-sized Canadian City

The role of safer injection facilities in the response to HIV/AIDS among injection drug users

Contact Info

Product

Resources

About